JCHOR
Journal of Current Hematology & Oncology Research

The Journal of Current Hematology & Oncology Research regularly publishes internationally qualified research in hematology and oncology within the current scholarly knowledge.

ISSN: Active
eISSN: 2980-0854
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

ViewAll
Cover and Contents

Cover and Contents

Full Issue

Full Issue

Articles

Original Article - Hematology

Hereditary thrombophilia and recurrent pregnancy loss: is it time to reassess routine genetic testing?

https://doi.org/10.51271/JCHOR-0057

: -382 : 1229

Citation : Beyler Ö, Baş H, Balık B, et al. Hereditary thrombophilia and recurrent pregnancy loss: is it time to reassess routine genetic testing? J Curr Hematol Oncol Res. 2025;3(2):22-26.

https://doi.org/10.51271/JCHOR-0058

: -34 : 771

Citation : Yılmaz Ürün Y, Ürün M. Evaluation of second-line treatment options in metastatic esophageal squamous cell carcinoma. J Curr Hematol Oncol Res. 2025;3(2):27-31.

Original Article - Oncology

The relationship between medical therapy and sarcopenia in advanced non-small cell lung cancer patients

https://doi.org/10.51271/JCHOR-0059

: 343 : 435

Citation : Erdem Keleş F, Yalçın S, Keleş AO, Erdem TE, Bozkurt Yavuz H, Ayçiçek GŞ. The relationship between medical therapy and sarcopenia in advanced non-small cell lung cancer patients. J Curr Hematol Oncol Res. 2025;3(2):32-41.

Case Report - Hematology

Familial hemophagocytic lymphohistiocytosis case in adult age

https://doi.org/10.51271/JCHOR-0060

: 117 : 623

Citation : Fidan K, Çilek HG, Çelik S, et al. Familial hemophagocytic lymphohistiocytosis case in adult age: case report. J Curr Hematol Oncol Res. 2025;3(2):42-45.

Case Report - Hematology

Secondary cutaneous diffuse large B-Cell lymphomas: bad scenario

https://doi.org/10.51271/JCHOR-0061

: -115 : 749

Citation : Demircioğlu S, Çiftçi MG, Baysal S, Merter M, Tekinalp A. Secondary cutaneous diffuse large B-cell lymphomas: bad scenario. J Curr Hematol Oncol Res. 2025;3(2):46-48.
_Footer